Host: |
Rabbit |
Applications: |
WB/IF |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CDC34 (150-236) is suitable for use in Western Blot and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:1000IF/ICC 1:50-1:200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CDC34 |
Gene ID: |
997 |
Uniprot ID: |
UB2R1_HUMAN |
Immunogen Region: |
150-236 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 150-236 of human CDC34 (NP_004350.1). |
Immunogen Sequence: |
KWKESKGKDREYTDIIRKQV LGTKVDAERDGVKVPTTLAE YCVKTKAPAPDEGSDLFYDD YYEDGEVEEEADSCFGDDED DSGTEES |
Tissue Specificity | Expressed in testes during spermatogenesis to regulate repression of cAMP-induced transcription. |
Post Translational Modifications | Autoubiquitinated. Autoubiquitination is promoted by the human herpes virus 1 protein ICP0 and leads to degradation by the Ubiquitin-proteasomal pathway. Phosphorylated by CK2. Phosphorylation of the C-terminal tail by CK2 controls the nuclear localization. |
Function | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination. Cooperates with the E2 UBCH5C and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Performs ubiquitin chain elongation building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. UBE2D3 acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Cooperates with the SCF(SKP2) E3 ligase complex to regulate cell proliferation through ubiquitination and degradation of MYBL2 and KIP1. Involved in ubiquitin conjugation and degradation of CREM isoform ICERIIgamma and ATF15 resulting in abrogation of ICERIIgamma- and ATF5-mediated repression of cAMP-induced transcription during both meiotic and mitotic cell cycles. Involved in the regulation of the cell cycle G2/M phase through its targeting of the WEE1 kinase for ubiquitination and degradation. Also involved in the degradation of beta-catenin. Is target of human herpes virus 1 protein ICP0, leading to ICP0-dependent dynamic interaction with proteasomes. |
Protein Name | Ubiquitin-Conjugating Enzyme E2 R1(E3-Independent E2 Ubiquitin-Conjugating Enzyme R1E2 Ubiquitin-Conjugating Enzyme R1Ubiquitin-Conjugating Enzyme E2-32 Kda ComplementingUbiquitin-Conjugating Enzyme E2-Cdc34Ubiquitin-Protein Ligase R1 |
Database Links | Reactome: R-HSA-202424Reactome: R-HSA-2871837Reactome: R-HSA-5607764Reactome: R-HSA-8866652Reactome: R-HSA-983168 |
Cellular Localisation | CytoplasmNucleusThe Phosphorylation Of The C-Terminal Tail Plays An Important Role In Mediating Nuclear LocalizationColocalizes With Beta-Tubulin On Mitotic Spindles In Anaphase |
Alternative Antibody Names | Anti-Ubiquitin-Conjugating Enzyme E2 R1 antibodyAnti-(E3-Independent E2 Ubiquitin-Conjugating Enzyme R1 antibodyAnti-E2 Ubiquitin-Conjugating Enzyme R1 antibodyAnti-Ubiquitin-Conjugating Enzyme E2-32 Kda Complementing antibodyAnti-Ubiquitin-Conjugating Enzyme E2-Cdc34 antibodyAnti-Ubiquitin-Protein Ligase R1 antibodyAnti-CDC34 antibodyAnti-UBCH3 antibodyAnti-UBE2R1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance